Latest News about OCX
Recent news which mentions OCX
Earnings Scheduled For May 11, 2022
May 11, 2022
From Benzinga
Oncocyte Reports It's Ready To Enter The $3.6 Billion Transplant Diagnostics Market In First Half Of 2022
May 05, 2022
Tickers
OCX
From Benzinga
From Benzinga
2 Stocks Under $2 Insiders Are Aggressively Buying
April 19, 2022
From Benzinga
4 Stocks Under $5 Insiders Are Aggressively Buying
April 18, 2022
From Benzinga
From Benzinga
From InvestorPlace
Oncocyte And Thermo Fisher Report Teaming Up To Bring Precision Medicine To Cancer Patients Worldwide
April 12, 2022
Tickers
OCX
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
From Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
From Benzinga
Meet A Company Creating Diagnostic Solutions to Enhance Lung Cancer Treatment And Care
January 25, 2022
Tickers
OCX
From Benzinga
52 Biggest Movers From Yesterday
January 20, 2022
From Benzinga
Mid-Afternoon Market Update: Dow Tumbles 150 Points; Yumanity Therapeutics Shares Plunge
January 19, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 19, 2022
From Benzinga
From Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
January 19, 2022
From Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
From Benzinga
65 Biggest Movers From Yesterday
January 19, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 18, 2022
From Benzinga
Benzinga Announces This Week's All Access Guests
January 18, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 29, 2021
From Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
From Benzinga
How Bad Are OncoCyte Corporation Common Stock's Earnings? | Return On Capital Employed
November 09, 2021
Tickers
OCX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.